18.02.2019 DEINOVE announces its financial calendar for 2019 DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-...
31.01.2019 Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner The test design has been improved for a better assessment of DNV3837 effectiveness in treating Clostridium difficile infections, This will...
10.01.2019 A new website to highlight DEINOVE’s disruptive innovation strategy The new DEINOVE website displays an updated presentation of DEINOVE’s corporate activities and identity It illustrates the disruptive...
22.11.2018 Deinove will market a 2nd proprietary carotenoid-based cosmetic active ingredient in 2019 After launching Phyt-N-Resist® in 2018, Deinove is developing on its own a 2 nd innovative bio-based carotenoid for the cosmetics market...
21.11.2018 DEINOVE confirms its financing options by renewing its equity line The equity line funding set up in December 2014 expired. It has enabled DEINOVE to raise €9.4 million net in a flexible, optimized manner...
24.10.2018 DEINOVE to collaborate with CALIBR to explore broadly the anti-infectious potentials of its bacterial collection CALIBR is a division of the Scripps Research, a California non-profit corporation, dedicated to finding new treatments addressing unmet...
02.10.2018 Strategic partnership between DEINOVE and SOLVAY for the marketing of phytoene in North America and Asia Solvay Novecare will market Phytoene as a cosmetic active ingredient in North America and Asia under the name ReGeN-oPhyt® This agreement...
28.09.2018 Deinove is the regional winner of the ‘PME Bougeons-nous’ awards in the ‘creative business’ category The “PME Bougeons-nous” awards, organized by RMC, is the leading SME contest in France; DEINOVE was selected as the regional winner of the...
27.09.2018 2018 half-year consolidated results: strengthened financial situation, substantial progress in both areas of business Cash position: +€9.9m at June 30, 2018 compared to +€4.9m at December 31, 2017 thanks to the reinforcement of shareholders' equity Half-...
13.09.2018 Strategic partnership between DEINOVE and UNIVAR for the distribution of Phyt-N-Resist® in the EMEA zone UNIVAR will distribute the Phyt-N-Resist ® cosmetic active ingredient in the EMEA zone; UNIVAR is a world leader in the distribution of...